Methylprednisolone
Back to searchMolecule Structure
Scientific Name
Methylprednisolone
Description of the Drug
Methylprednisolone is a corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00959
http://www.drugbank.ca/drugs/DB00959
Brand Name(s)
Medrol, Medrone, Methylprednisolone
Company Owner(s)
Heather Drug Co Inc, Sandoz Inc, Watson Laboratories Inc, Novast Laboratories Ltd, Par Pharmaceutical Inc, Praxgen Pharmaceuticals Llc, Invatech Pharma Solutions Llc, Lupin Ltd, Tianjin Tianyao Pharmaceuticals Co Ltd, Amneal Eu Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
| Atlas | methylprednisolone | |
| SureChEMBL | SCHEMBL5084 | |
| PharmGKB | PA450466 | |
| Human Metabolome Database | HMDB0015094 | |
| DrugBank | DB00959 | |
| PubChem: Thomson Pharma | 14853277 | 14779784 |
| PubChem | 6741 | |
| LINCS | LSM-5485 | |
| Nikkaji | J3.872E | |
| BindingDB | 50103616 | |
| EPA CompTox Dashboard | DTXSID7023300 | |
| LipidMaps | LMST02030178 | |
| DrugCentral | 1768 | |
| Brenda | 67546 | |
| ChemicalBook | CB3274376 | |
| Guide to Pharmacology | 7088 | |
| rxnorm | MEDROL | METHYLPREDNISOLONE |
| ChEBI | 6888 | |
| ZINC | ZINC000003875560 |
